Pattern recognition receptor (PRR) (PRR)

Pattern recognition receptors (PRRs) are a diverse group of germline-encoded host sensors that form the front line of the innate immune system. They are primarily expressed by antigen-presenting cells such as macrophages, dendritic cells, and neutrophils, where they identify pathogen-associated molecular patterns (PAMPs) like lipopolysaccharides or viral RNA, as well as damage-associated molecular patterns (DAMPs) from dying host cells (PMID: 24321394). Major families include Toll-like receptors (TLRs), NOD-like receptors (NLRs), RIG-I-like receptors (RLRs), and C-type lectin receptors (CLRs). Upon ligand binding, PRRs initiate signaling cascades—typically involving the NF-κB or IRF pathways—that lead to the expression of pro-inflammatory cytokines and type I interferons (PMID: 30503229). In therapeutic contexts, PRR agonists are widely utilized as vaccine adjuvants to enhance immunogenicity or as immunotherapies to turn "cold" tumors "hot" by stimulating the tumor microenvironment (PMID: 31034638). For example, Imiquimod targets TLR7 to treat skin cancers, while Mifamurtide targets NOD2 for osteosarcoma. Conversely, the dysregulation or overactivation of PRRs is implicated in chronic inflammatory conditions, sepsis, and autoimmune diseases, making PRR antagonists a significant area of drug development (PMID: 29777215). Their central role in coordinating the transition from innate to adaptive immunity makes them critical targets for modulating host defense and inflammatory homeostasis.

Other names

Pathogen recognition receptorInnate immune receptorPRRsHost immune cell pattern recognition receptors

Toll-like receptor 7 agonist, Toll-like receptor 9 agonist, NOD2 receptor agonist, Toll-like receptor 4 agonist, Toll-like receptor 7/8 agonist, Pattern recognition receptor antagonist